Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patients?

Felicetto Ferrara, Pellegrino Musto

Research output: Contribution to journalArticle

Abstract

The research with new agents is particularly active in acute myeloid leukemia (AML) and different studies suggest a potential utility of hypomethylating (HMA) agents in this disease. In this article, we critically appraise some recent clinical data reported on the use of HMA for the treatment of AML in older patient.

Original languageEnglish
Pages (from-to)3879-3881
Number of pages3
JournalCancer
Volume117
Issue number17
DOIs
Publication statusPublished - Sep 1 2011

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patients?'. Together they form a unique fingerprint.

  • Cite this